Communications Medicine,
Journal Year:
2024,
Volume and Issue:
4(1)
Published: March 5, 2024
Abstract
Background
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
is
a
prevalent
chronic
worldwide,
and
can
rapidly
progress
to
metabolic
steatohepatitis
(MASH).
Accurate
preclinical
models
methodologies
are
needed
understand
underlying
mechanisms
develop
treatment
strategies.
Through
meta-analysis
of
currently
proposed
mouse
models,
we
hypothesized
that
diet-
chemical-induced
MASH
model
closely
resembles
the
observed
lipid
metabolism
alterations
in
humans.
Methods
We
developed
transcriptomics-driven
pathway
analysis
(TDMPA),
method
aid
evaluation
resemblance.
TDMPA
uses
genome-scale
calculate
enzymatic
reaction
perturbations
from
gene
expression
data.
performed
score
compare
human
signatures.
used
an
already-established
WD+CCl4-induced
functional
assays
lipidomics
confirm
findings.
Results
Both
exhibit
numerous
altered
pathways,
including
triglyceride
biosynthesis,
fatty
acid
beta-oxidation,
bile
cholesterol
metabolism,
oxidative
phosphorylation.
significant
reduction
mitochondrial
functions
bioenergetics,
as
well
acylcarnitines
for
model.
identify
wide
range
species
within
most
perturbed
pathways
predicted
by
TDMPA.
Triglycerides,
phospholipids,
acids
increased
significantly
liver,
confirming
our
initial
observations.
Conclusions
introduce
TDMPA,
methodology
evaluating
disorders.
By
comparing
signatures
typify
MASH,
show
good
resemblance
WD+CCl4
Our
presented
approach
provides
valuable
tool
defining
space
experimental
design
assessing
metabolism.
Metabolites,
Journal Year:
2023,
Volume and Issue:
13(7), P. 855 - 855
Published: July 18, 2023
Recent
advancements
in
omics
technologies
have
generated
a
wealth
of
biological
data.
Integrating
these
data
within
mathematical
models
is
essential
to
fully
leverage
their
potential.
Genome-scale
metabolic
(GEMs)
provide
robust
framework
for
studying
complex
systems.
GEMs
significantly
contributed
our
understanding
human
metabolism,
including
the
intrinsic
relationship
between
gut
microbiome
and
host
metabolism.
In
this
review,
we
highlight
contributions
discuss
critical
challenges
that
must
be
overcome
ensure
reproducibility
enhance
prediction
accuracy,
particularly
context
precision
medicine.
We
also
explore
role
machine
learning
addressing
GEMs.
The
integration
with
has
potential
lead
new
insights,
advance
molecular
mechanisms
health
disease.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Aug. 21, 2023
Abstract
The
growing
availability
of
single-cell
and
spatially-resolved
transcriptomics
has
led
to
the
rapidly
popularity
methods
infer
cell-cell
communication.
Many
approaches
have
emerged,
each
capturing
only
a
partial
view
complex
landscape
Here,
we
present
LIANA+,
scalable
framework
decode
coordinated
inter-
intracellular
signalling
events
from
single-
multi-condition
datasets
in
both
data.
Beyond
integrating
extending
established
methodologies
rich
knowledge
base,
LIANA+
enables
novel
analyses
using
diverse
molecular
mediators,
including
those
measured
multi-omics
Accessible
as
an
open-source
Python
package
at
https://github.com/saezlab/liana-py
,
provides
comprehensive
set
synergistic
components
study
Figure
Biology,
Journal Year:
2024,
Volume and Issue:
13(11), P. 848 - 848
Published: Oct. 22, 2024
With
the
advent
of
high-throughput
technologies,
field
omics
has
made
significant
strides
in
characterizing
biological
systems
at
various
levels
complexity.
Transcriptomics,
proteomics,
and
metabolomics
are
three
most
widely
used
each
providing
unique
insights
into
different
layers
a
system.
However,
analyzing
data
set
separately
may
not
provide
comprehensive
understanding
subject
under
study.
Therefore,
integrating
multi-omics
become
increasingly
important
bioinformatics
research.
In
this
article,
we
review
strategies
for
transcriptomics,
data,
including
co-expression
analysis,
metabolite-gene
networks,
constraint-based
models,
pathway
enrichment
interactome
analysis.
We
discuss
combined
integration
approaches,
correlation-based
strategies,
machine
learning
techniques
that
utilize
one
or
more
types
data.
By
presenting
these
methods,
aim
to
researchers
with
better
how
integrate
gain
view
system,
facilitating
identification
complex
patterns
interactions
might
be
missed
by
single-omics
analyses.
Journal of Proteome Research,
Journal Year:
2024,
Volume and Issue:
23(2), P. 532 - 549
Published: Jan. 17, 2024
Since
2010,
the
Human
Proteome
Project
(HPP),
flagship
initiative
of
Organization
(HUPO),
has
pursued
two
goals:
(1)
to
credibly
identify
protein
parts
list
and
(2)
make
proteomics
an
integral
part
multiomics
studies
human
health
disease.
The
HPP
relies
on
international
collaboration,
data
sharing,
standardized
reanalysis
MS
sets
by
PeptideAtlas
MassIVE-KB
using
Guidelines
for
quality
assurance,
integration
curation
non-MS
neXtProt,
plus
extensive
use
antibody
profiling
carried
out
Protein
Atlas.
According
neXtProt
release
2023-04-18,
expression
now
been
detected
(PE1)
18,397
19,778
predicted
proteins
coded
in
genome
(93%).
Of
these
PE1
proteins,
17,453
were
with
mass
spectrometry
(MS)
accordance
944
a
variety
methods.
number
PE2,
PE3,
PE4
missing
stands
at
1381.
Achieving
unambiguous
identification
93%
encoded
from
across
all
chromosomes
represents
remarkable
experimental
progress
list.
Meanwhile,
there
are
several
categories
that
have
proved
resistant
detection
regardless
protein-based
methods
used.
Additionally
some
PE1–4
probably
should
be
reclassified
PE5,
specifically
21
LINC
entries
∼30
HERV
entries;
being
addressed
present
year.
Applying
wide
array
biological
clinical
ensures
other
omics
platforms
as
reported
Biology
Disease-driven
teams
pathology
resource
pillars.
Current
positioned
transition
its
Grand
Challenge
focused
determining
primary
function(s)
every
itself
networks
pathways
within
context
Communications Medicine,
Journal Year:
2024,
Volume and Issue:
4(1)
Published: March 5, 2024
Abstract
Background
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
is
a
prevalent
chronic
worldwide,
and
can
rapidly
progress
to
metabolic
steatohepatitis
(MASH).
Accurate
preclinical
models
methodologies
are
needed
understand
underlying
mechanisms
develop
treatment
strategies.
Through
meta-analysis
of
currently
proposed
mouse
models,
we
hypothesized
that
diet-
chemical-induced
MASH
model
closely
resembles
the
observed
lipid
metabolism
alterations
in
humans.
Methods
We
developed
transcriptomics-driven
pathway
analysis
(TDMPA),
method
aid
evaluation
resemblance.
TDMPA
uses
genome-scale
calculate
enzymatic
reaction
perturbations
from
gene
expression
data.
performed
score
compare
human
signatures.
used
an
already-established
WD+CCl4-induced
functional
assays
lipidomics
confirm
findings.
Results
Both
exhibit
numerous
altered
pathways,
including
triglyceride
biosynthesis,
fatty
acid
beta-oxidation,
bile
cholesterol
metabolism,
oxidative
phosphorylation.
significant
reduction
mitochondrial
functions
bioenergetics,
as
well
acylcarnitines
for
model.
identify
wide
range
species
within
most
perturbed
pathways
predicted
by
TDMPA.
Triglycerides,
phospholipids,
acids
increased
significantly
liver,
confirming
our
initial
observations.
Conclusions
introduce
TDMPA,
methodology
evaluating
disorders.
By
comparing
signatures
typify
MASH,
show
good
resemblance
WD+CCl4
Our
presented
approach
provides
valuable
tool
defining
space
experimental
design
assessing
metabolism.